Pharmacovigilance Considerations for Biosimilars in the USA
Crossref DOI link: https://doi.org/10.1007/s40259-015-0137-2
Published Online: 2015-09-29
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grampp, Gustavo
Felix, Thomas
Funding for this research was provided by:
Amgen Inc.
License valid from 2015-09-29